Keyphrases
National Surgical Quality Improvement Program (NSQIP)
73%
Colectomy
71%
Glucose Transporter 2 (GLUT2)
71%
Breast
66%
Crohn's Disease
52%
Colon Surgery
52%
Enterocyte
51%
Antisepsis
47%
Peptide Transporter 1 (PepT1)
47%
Inflammatory Bowel Disease
47%
Glucose Uptake
44%
Colorectal Cancer
38%
Retrospective Cohort Study
34%
Apical Membrane
33%
Adaptation
31%
Colorectal Surgery
30%
Single Institution
29%
Transporter-mediated Uptake
28%
Everted
28%
Mayo Clinic
26%
Jejunum
26%
Low Dose Rate
26%
Lessons Learned
23%
Perioperative Antibiotic Prophylaxis
23%
Inflammatory Breast Cancer
23%
Surgical Technique
23%
Passive Uptake
23%
Postoperative Recurrence
23%
Infectious Complications
23%
Superficial Surgical Site Infection
23%
Gastrointestinal Reconstruction
23%
Opioid Prescribing
23%
Intestinal Adaptation
23%
Opioids
23%
Positive Sentinel Node
23%
Unusual Case
23%
Innervation
23%
Lymph Node-positive Breast Cancer
23%
Rectal Adenocarcinoma
23%
Colon Resection
23%
Breast Procedures
23%
Early-onset Colorectal Cancer (EOCRC)
23%
Randomized Controlled Trial
23%
Anal Sac Adenocarcinoma
23%
American Society
23%
Negative Pressure Wound Therapy
23%
Prediction Model
23%
Non-sentinel Lymph Node Metastasis
23%
Oligopeptides
23%
Primary Angiosarcoma
23%
Medicine and Dentistry
Quality Improvement
100%
Colectomy
95%
Inflammatory Bowel Disease
71%
Breast Cancer
50%
Glucose Transporter 2
47%
Colorectal Carcinoma
43%
Neoplasm
42%
Crohn's Disease
40%
Retrospective Cohort Study
37%
Glucose Uptake
37%
Lymph Node Metastasis
35%
Surgery
33%
Postoperative Complication
32%
Surgical Infection
31%
Surgical Anastomosis
31%
Ulcerative Colitis
31%
Colon Surgery
29%
Recurrent Disease
29%
Surgeon
29%
Apical Membrane
29%
Diseases
29%
Anastomosis Leakage
28%
Dysplasia
27%
Infection
27%
Biological Product
27%
Breast Reconstruction
26%
Sentinel Lymph Node
25%
Mastectomy
24%
Negative Pressure Wound Therapy
23%
Carcinoma
23%
Abdominal Wall
23%
Surgical Technique
23%
Incision
23%
Sentinel Node
23%
COVID-19
23%
Colon Carcinoma
23%
Angiosarcoma
23%
Infectious Complication
23%
Antibiotic Prophylaxis
23%
Adenocarcinoma
23%
Rectum Carcinoma
23%
Inflammatory Breast Cancer
23%
Small Intestine Resection
23%
Fistula
23%
Nodal Metastasis
23%
Oligopeptide
23%
Neoadjuvant Chemotherapy
23%
Liver Metastasis
23%
Peptide Transporter 1
23%
Prosthetics
23%